Clinical Trials Directory

Trials / Terminated

TerminatedNCT00910416

The Comparability of Bispectral Index and Neurosense During Anesthesia

The Comparability of Bispectral Index and Neurosense During Total Intravenous Anesthesia and Balanced Anesthesia

Status
Terminated
Phase
Study type
Observational
Enrollment
40 (actual)
Sponsor
Hopital Foch · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

The assessment of anesthesia depth was based, until recently, on the evolution of hemodynamic parameters. Nowadays it can be evaluated by several monitoring methods, derived from electroencephalogram analysis, namely the Bispectral Index (Aspect Medical Systems, Newton, USA). A new modality is currently under development: the NeuroSENSE (Cleveland Medical Devices Inc., Cleveland, OH 44103, USA). The goal of this study is to compare both monitoring modalities during anesthesia.

Conditions

Interventions

TypeNameDescription
DRUGpropofol, remifentanil, atracuriumpropofol, remifentanil, atracurium dosages are adapted according to clinician's judgment
DRUGpropofol, remifentanil, atracurium, sevofluranedosages are adapted according to clinician's judgment
DEVICEEEG monitoringsimultaneous monitoring with Bis and Neurosense

Timeline

Start date
2009-05-01
Primary completion
2010-12-01
Completion
2010-12-01
First posted
2009-05-29
Last updated
2016-09-23

Locations

1 site across 1 country: France

Source: ClinicalTrials.gov record NCT00910416. Inclusion in this directory is not an endorsement.